A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...
Measuring the lymphocytes—white blood cells that fight infection—in a patient's blood can be used to predict outcomes in ...
A laboratory study out of Roswell Park Comprehensive Cancer Center outlines a new way to boost the effectiveness of chimeric ...
Exicure shares trade higher after Phase 2 data show nearly 90% of patients reached key cell collection targets using its ...
Exicure’s investigational small molecule succeeded in mobilizing key blood-forming cells in almost 90% of patients in a phase ...
News-Medical.Net on MSN
Lymphocyte levels help predict outcomes after CAR T-cell therapy in non-Hodgkin lymphoma
Measuring the lymphocytes - white blood cells that fight infection - in a patient's blood can be used to predict outcomes in ...
News-Medical.Net on MSN
Genome-edited immune cell therapy shows promise for treating aggressive blood cancer
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in ...
A small group of patients with an otherwise incurable form of T‑cell leukaemia have seen their cancer driven into remission ...
The tiny pantheon known as the Asgard archaea bear traits that hint at how plants, animals and fungi emerged on Earth.
One therapy wey pipo bin once reason as achievement for science fiction don reverse aggressive and incurable blood cancers ...
A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results